Obesity Trial, Recruiting NCT07245979 Sponsor: Poznan University of Life Sciences Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07245979
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female
  • People between the ages of 40 and 65 years old
  • People with a BMI (a measure of body weight relative to height) above 25, which is considered overweight or obese

Who may not be able to join:

  • People who are male
  • People with a BMI below 25
  • People who have taken sirtuin activator supplements (a type of compound thought to affect ageing-related proteins) in the 3 months before the study
  • People who are pregnant or breastfeeding
  • People who have recently been on a diet or are currently following a calorie-restricted eating plan
  • People who are currently taking medication to treat obesity, diabetes, or high cholesterol
  • People who have previously had weight-loss (bariatric) surgery
  • People who have diabetes
  • People who have or have had cancer
  • People with long-term (chronic) kidney disease, liver disease, or autoimmune conditions (where the body's immune system attacks itself)
  • People with an alcohol addiction

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Agata Chmurzynska, Professor, Poznan Univeristy of Life Sciences

Phone: +486184661

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poznan University of Life Sciences
Registry
ClinicalTrials.gov
Start date
8 October 2025
Est. completion
30 November 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Concentrations of blood lipids; Blood glucose concentrations; Ageing biomarkers: transcription level of the p16INK4a gene in peripheral blood mononuclear cells; Ageing biomarkers: telomere lenght; Ageing biomarkers: SA beta galactosidase activity; Oxidative stress

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov